Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Immunotherapy, Adoptive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchUnknownNCT03910842
What this trial is testing

Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy

Who this might be right for
Non-Hodgkin Lymphoma of IntestineLeukemia
Timmune Biotech Inc. 12
Testing effectiveness (Phase 2)Temporarily pausedNCT05138458
What this trial is testing

MT-101 in Subjects With CD5+ Relapsed/Refractory TCL

Who this might be right for
Lymphoma, T-Cell, PeripheralLymphoma, T-Cell, CutaneousMycosis Fungoides+2 more
Myeloid Therapeutics 40
Early research (Phase 1)Looking for participantsNCT06904066
What this trial is testing

Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies

Who this might be right for
Malignancy, HematologicNeoplasms, HematologicNeoplasms, Hematopoietic+8 more
National Cancer Institute (NCI) 86
Early research (Phase 1)Temporarily pausedNCT00160992
What this trial is testing

Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients

Who this might be right for
Melanoma
University of Lausanne Hospitals 6
Testing effectiveness (Phase 2)Ended earlyNCT02508324
What this trial is testing

IPA Targeted Adoptive Immunotherapy vs Adult Haplo-identical Cell Infusion During Induction of High Risk Leukemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Weill Medical College of Cornell University 43
Early research (Phase 1)Study completedNCT02145325
What this trial is testing

Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients

Who this might be right for
End Stage Renal Disease
Northwestern University 10
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Testing effectiveness (Phase 2)WithdrawnNCT04344548
What this trial is testing

Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia

Who this might be right for
COVID
Universidad Nacional de Colombia
Testing effectiveness (Phase 2)Ended earlyNCT01236573
What this trial is testing

Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes

Who this might be right for
Skin CancerMetastatic Melanoma
National Institutes of Health Clinical Center (CC) 34
Early research (Phase 1)Looking for participantsNCT02870244
What this trial is testing

Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Who this might be right for
Melanoma
Loyola University 18
Early research (Phase 1)Study completedNCT03441100
What this trial is testing

TCR-engineered T Cells in Solid Tumors: IMA202-101

Who this might be right for
Solid Tumor, AdultRefractory CancerRecurrent Cancer+1 more
Immatics US, Inc. 16
Testing effectiveness (Phase 2)Ended earlyNCT03645928
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors

Who this might be right for
Metastatic MelanomaSquamous Cell Carcinoma of the Head and NeckNon-small Cell Lung Cancer
Iovance Biotherapeutics, Inc. 225
Early research (Phase 1)Study completedNCT00000756
What this trial is testing

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15
Testing effectiveness (Phase 2)Looking for participantsNCT05442515
What this trial is testing

CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B-NHLB-Non Hodgkin LymphomaAcute Lymphocytic Leukemia+8 more
National Cancer Institute (NCI) 130
Testing effectiveness (Phase 2)Study completedNCT00588913
What this trial is testing

Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases

Who this might be right for
Kidney CancerMetastatic Cancer
Tokyo Women's Medical University 20
Not applicableEnded earlyNCT01851395
What this trial is testing

Rapid Autopsy and Procurement of Cancer Tissue

Who this might be right for
Thymus TumorsAdoptive Cellular TherapyMesothelioma+2 more
National Cancer Institute (NCI) 32
Early research (Phase 1)Ended earlyNCT03680560
What this trial is testing

Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers

Who this might be right for
Solid TumorHER-2 Protein Overexpression
Cogent Biosciences, Inc. 6
Very early researchUnknownNCT04191941
What this trial is testing

Treatment of Hematological Malignancy With Novel CAR-T Cells.

Who this might be right for
B-cell Non Hodgkin LymphomaB-cell Acute Lymphoblastic LeukemiaMultiple Myeloma
Timmune Biotech Inc. 9
Early research (Phase 1)Looking for participantsNCT06221553
What this trial is testing

Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG

Who this might be right for
DIPG Brain TumorDiffuse Intrinsic Pontine Glioma
Chulalongkorn University 9
Testing effectiveness (Phase 2)Study completedNCT01827579
What this trial is testing

Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT)

Who this might be right for
Haematological Malignancies
University College, London 37
Next Page